Overview

Integrated Biosciences develops therapies for age-related diseases using a platform that blends synthetic biology, AI-driven small-molecule drug discovery, optogenetics, chemistry, and computation. The platform helps scientists understand complex cellular stress biology and identify compounds that modulate stress responses linked to neurodegeneration, cancer, and diabetes. Drugs are discovered and developed through research and development efforts, with the goal of bringing new therapeutics to patients. Unlike traditional pharma approaches that rely on a single method, Integrated Biosciences combines biology engineering, machine learning, and precision chemistry to accelerate the discovery and optimization of drug candidates.

Significant Headcount Growth